Topical gentamicin for the prevention of tunneled hemodialysis catheter-related infections: a randomized double-blind study

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.creatorCaetano, Camille Pereira-
Autor(es): dc.creatorCassimiro, Vanessa Piacitelli-
Autor(es): dc.creatorDionisio, Daniele Lopes-
Autor(es): dc.creatorPereira, Viviane Pollo-
Autor(es): dc.creatorRodrigues, Elisabete Aparecida Crispim-
Autor(es): dc.creatorRosa, Priscila Nunes-
Autor(es): dc.creatorElias, Daniele Aparecida-
Autor(es): dc.creatorPonce, Daniela-
Data de aceite: dc.date.accessioned2025-08-21T16:25:33Z-
Data de disponibilização: dc.date.available2025-08-21T16:25:33Z-
Data de envio: dc.date.issued2023-07-29-
Data de envio: dc.date.issued2023-07-29-
Data de envio: dc.date.issued2022-12-31-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1007/s40620-023-01615-x-
Fonte completa do material: dc.identifierhttp://hdl.handle.net/11449/247304-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/247304-
Descrição: dc.descriptionIntroduction: Infection is the second leading cause of death in dialysis patients, with catheter-related bloodstream infection being the most serious. Exit Site Infection and Tunnel Infection are also related to the catheter. Objective: To compare the infection rates achieved with the application of either topical gentamicin or placebo to the exit-site of tunneled catheters filled with locking solution in chronic hemodialysis patients. Methods: This randomized double-blind clinical trial compared the application of 0.1% gentamicin versus placebo to the exit site of tunneled hemodialysis catheters filled with a prophylactic locking solution. A total of 91 patients were randomly allocated to 2 groups: placebo or 0.1% gentamicin. Results: Mean patient age was 60.4 (+ 15.3) years, with predominance of males (60.4%). The main cause of chronic kidney disease was diabetes (40.7%). The rates of exit site infection (placebo = 30% vs. gentamicin = 34.1%, p = 0.821), and bloodstream infection (placebo = 22% vs. gentamicin = 17.1%, p = 0.60), as well as both exit site infection and bloodstream infection incidence density per 1000 catheter-days (p = 1) did not differ between groups. The infection-free curve was also similar in both groups. Conclusion: The application of topical 0.1% gentamicin to the exit site of tunneled catheters filled with lock solution did not reduce infectious complications when compared to topical placebo in patients on chronic hemodialysis. Graphical abstract: [Figure not available: see fulltext.].-
Descrição: dc.descriptionUNESP FMB: Universidade Estadual Paulista Julio de Mesquita Filho Faculdade de Medicina Campus de Botucatu, São Paulo-
Descrição: dc.descriptionUNESP FMB: Universidade Estadual Paulista Julio de Mesquita Filho Faculdade de Medicina Campus de Botucatu, São Paulo-
Idioma: dc.languageen-
Relação: dc.relationJournal of Nephrology-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectCatheter-related infections-
Palavras-chave: dc.subjectCentral venous catheters-
Palavras-chave: dc.subjectHemodialysis-
Palavras-chave: dc.subjectTunneled catheter-
Título: dc.titleTopical gentamicin for the prevention of tunneled hemodialysis catheter-related infections: a randomized double-blind study-
Tipo de arquivo: dc.typelivro digital-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.